JIM CRAMERThe Heat Is On: Cramer's 'Mad Money' Recap (Thursday 1/16/20)By Scott RuttJan 16, 2020 8:59 PM EST
PRESS RELEASESInogen Announces Preliminary, Unaudited Full Year And Fourth Quarter 2019 Revenue ResultsBy Business WireJan 13, 2020 8:05 AM EST
JIM CRAMERStatus Quo Great for Stocks: Cramer's 'Mad Money' RecapBy Scott RuttMay 5, 2019 11:33 AM EDT
JIM CRAMERInternational Paper, Inogen, Teva Pharmaceuticals: 'Mad Money' Lightning RoundBy Scott RuttAug 16, 2017 6:36 AM EDT
JIM CRAMERFantasy Football and Picking Stocks: Cramer's 'Mad Money' RecapBy Scott RuttAug 16, 2017 5:59 AM EDT
MARKETSInogen (INGN) Showing Signs Of Being Strong And Under The RadarBy TheStreet WireJul 7, 2016 10:15 AM EDT
OPINION3 biotech stocks with charts to watch -- and one bonus stock!By Harry BoxerApr 16, 2016 11:00 AM EDT
MARKETSInsider Trading Alert - INGN, HYGS And DXYN Traded By InsidersBy TheStreet WireApr 5, 2016 10:30 AM EDT
MARKETSInogen (INGN) Stock Spikes on Q4 Earnings Beat, GuidanceBy Kaya YurieffMar 15, 2016 3:42 PM EDT
MARKETSInsider Trading Alert - IMPR, INGN And APOL Traded By InsidersBy TheStreet WireOct 5, 2015 10:30 AM EDT
MARKETSInsider Trading Alert - INGN, WTS And RP Traded By InsidersBy TheStreet WireSep 4, 2015 11:00 AM EDT
MARKETSTrade-Ideas: Inogen (INGN) Is Today's Strong And Under The Radar StockBy TheStreet WireJun 18, 2015 9:54 AM EDT
